Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

IMPACT-Instrument to Measure Pain and Assess Correlation to Treatment. Create a smartphone pupillometry to objectively determine the presence of acute pain, evaluate opioid as the treatment for pain.

Award Number: R43DA046974
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/30/2019
PERIOD OF PERFORMANCE END DATE: 12/31/2022

Group Awards By:

View Award Description

IMPACT-Instrument to Measure Pain and Assess Correlation to Treatment. Create a smartphone pupillometry to objectively determine the presence of acute pain, evaluate opioid as the treatment for pain. - PROJECT SUMMARY/ABSTRACT While patient self-report of pain is currently the gold standard of pain measurement, accurate self-reports of pain may not be feasible in critically ill patients who are sedated and intubated, unconscious patients, or patients who are unable to verbally communicate their pain. Current research has shown that pupillary dilation (PD) is a reliable indicator of acute pain, and that measurement of pupil size changes may be useful in determining the intensity of pain experienced as well as the efficacy of an analgesia. There is also research demonstrating the value of pupillary unrest under ambient light (PUAL) as an objective marker of sensitivity to opioids, and the use of facial expression analysis to detect pain. IMPACT proposes pupillometry with a proprietary algorithm to measure both PD and PUAL, and facial expression analysis using computer vision. Through IMPACT, Benten proposes to provide clinicians with a device that helps them objectively determine the presence or absence of pain, assess opioid efficacy, and assist in deciding whether opioids should be the treatment of choice for a patient. The utimate goal of IMPACT is to revolutionize measurement and management of pain. The novel approach of measuring PD, PUAL, and facial expressions will help eliminate subjectivity in the diagnosis of pain, and avoid over-administration of opioids or administration of opioids to patients who are not suitable candidates for opioid treatment. IMPACT will demonstrate the feasibility of using pupil size changes and facial expressions to guide the diagnosis and treatment of pain, and compare results obtained to pain scores reported by patients on the NRS, to assess accuracy of pain measurement and effectiveness in pain alleviation. IMPACT will be designed and developed to serve the needs of patients who experience severe pain, and provide them with pain relief, through objection clinical decision-making. The aims of IMPACT are as follows: 1) Phase I Specific Aims: Develop IMPACT prototype and conduct a validity test with 25 subjects, to demonstrate the efficacy and validity of IMPACT versus a commercial pupilometer, and 2) Conduct a feasibility pilot test of IMPACT with 20 patients in the post-anesthesia care unit (PACU) of Christiana Care Health System (CCHS), to demonstrate the feasibility of IMPACT in determining pain and assessing opioid efficacy. The short-term impact will be an improvement in pain detection, and more objective clinical decision making regarding opioid administration. The long-term impact will be a decrease in the misuse of opioid medication, and the facilitation of objective measurement of symptoms in clinical settings.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2019	BENTEN TECHNOLOGIES, INC.	9408 GRANT AVE	MANASSAS	VA	20110	MANASSAS CITY	USA	Drug Use and Addiction Research Programs	000	1	11/16/2023	NEW	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2019	BENTEN TECHNOLOGIES INC	9408 GRANT AVENUE, SUITE 206	MANASSAS	VA	20110	MANASSAS CITY	USA	Drug Use and Addiction Research Programs	001	1	9/1/2022	NEW	$0
2022	2019	BENTEN TECHNOLOGIES INC	9408 GRANT AVENUE, SUITE 206	MANASSAS	VA	20110	MANASSAS CITY	USA	Drug Use and Addiction Research Programs	000	1	10/12/2021	NEW	$0
														Subtotal = $0

Issue Date FY: 2019 ( Subtotal = $338,947 )
2019	2019	BENTEN TECHNOLOGIES INC	9408 GRANT AVENUE, SUITE 206	MANASSAS	VA	20110	MANASSAS CITY	USA	Drug Use and Addiction Research Programs	000	1	9/17/2019	NEW	$338,947
2019	2019	BENTEN TECHNOLOGIES INC	9408 GRANT AVENUE, SUITE 206	MANASSAS	VA	20110	MANASSAS CITY	USA	Drug Use and Addiction Research Programs	001	1	9/18/2019	NEW	$0
														Subtotal = $338,947

Grand Total All Awards = $338,947

Top

All Categories

About

Search

Reports

Data Submission

Award Information

IMPACT-Instrument to Measure Pain and Assess Correlation to Treatment. Create a smartphone pupillometry to objectively determine the presence of acute pain, evaluate opioid as the treatment for pain.

Award Number: R43DA046974

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/30/2019

PERIOD OF PERFORMANCE END DATE: 12/31/2022

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer